Northern Trust’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$66.5M Buy
1,144,469
+110,289
+11% +$5.99M 0.01% 941
2025
Q4
$47.7M Sell
1,034,180
-39,166
-4% -$1.75M 0.01% 1137
2025
Q3
$38.7M Sell
1,073,346
-48,546
-4% -$1.61M ﹤0.01% 1293
2025
Q2
$36.5M Sell
1,121,892
-1,064
-0.1% -$34.9K 0.01% 1288
2025
Q1
$42.4M Sell
1,122,956
-37,045
-3% -$2.96M 0.01% 1182
2024
Q4
$95M Buy
1,160,001
+123,584
+12% +$12.3M 0.01% 743
2024
Q3
$118M Buy
1,036,417
+96,691
+10% +$8.71M 0.02% 592
2024
Q2
$71M Sell
939,726
-29,031
-3% -$1.98M 0.01% 790
2024
Q1
$66.2M Buy
968,757
+84,489
+10% +$5.85M 0.01% 822
2023
Q4
$55.5M Sell
884,268
-12,367
-1% -$642K 0.01% 935
2023
Q3
$45.7M Buy
896,635
+35,694
+4% +$1.76M 0.01% 1009
2023
Q2
$43M Buy
860,941
+192,639
+29% +$9.13M 0.01% 1061
2023
Q1
$25M Buy
668,302
+8,971
+1% +$381K 0.01% 1405
2022
Q4
$31.6M Buy
659,331
+175,439
+36% +$6.88M 0.01% 1225
2022
Q3
$11.6M Buy
483,892
+19,555
+4% +$496K ﹤0.01% 1879
2022
Q2
$10.1M Buy
464,337
+82,212
+22% +$1.9M ﹤0.01% 2026
2022
Q1
$9.23M Buy
382,125
+10,663
+3% +$233K ﹤0.01% 2196
2021
Q4
$8.84M Sell
371,462
-3,645
-1% -$84.8K ﹤0.01% 2320
2021
Q3
$9.52M Buy
375,107
+9,455
+3% +$229K ﹤0.01% 2310
2021
Q2
$8.23M Buy
365,652
+74,694
+26% +$1.53M ﹤0.01% 2504
2021
Q1
$5.75M Buy
290,958
+67,838
+30% +$1.71M ﹤0.01% 2668
2020
Q4
$5.93M Buy
223,120
+8,593
+4% +$319K ﹤0.01% 2576
2020
Q3
$10.6M Buy
+214,527
New +$8.54M ﹤0.01% 2082

Other funds holding PCVX